Maa Formulations Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 12-12-2024
- Paid Up Capital ₹ 3.50 M
as on 12-12-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2009
- Open Charges ₹ 2.50 Cr
as on 12-12-2024
- Satisfied Charges ₹ 2.00 Cr
as on 12-12-2024
About Maa Formulations
The Corporate was formerly known as The Maa Formulations Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2009. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹2.50 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Poonam Bajpai and Amit Bajpai serve as directors at the Company.
- CIN/LLPIN
U24119MP2007PTC019422
- Company No.
019422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2007
- Date of AGM
30 Sep 2009
- Date of Balance Sheet
31 Mar 2009
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Maa Formulations Private Limited offer?
Maa Formulations Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Syrup.
Who are the key members and board of directors at Maa Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Bajpai  | Director | 25-Jul-2009 | Current |
| Amit Bajpai | Additional Director | 16-Jun-2021 | Current |
Financial Performance of Maa Formulations.
Enhance accessibility to Maa Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Maa Formulations?
Unlock access to Maa Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Feb 2010 | ₹2.50 Cr | Open |
Bank Of India Creation Date: 23 May 2008 | ₹1.50 Cr | Satisfied |
Bank Of Maharashtra Creation Date: 12 Oct 2007 | ₹5.00 M | Satisfied |
How Many Employees Work at Maa Formulations?
Unlock and access historical data on people associated with Maa Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maa Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maa Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
